These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 17854052

  • 1. A hybrid Bayesian-frequentist approach to evaluate clinical trial designs for tests of superiority and non-inferiority.
    Shao Y, Mukhi V, Goldberg JD.
    Stat Med; 2008 Feb 20; 27(4):504-19. PubMed ID: 17854052
    [Abstract] [Full Text] [Related]

  • 2. Modified Haybittle-Peto group sequential designs for testing superiority and non-inferiority hypotheses in clinical trials.
    Lai TL, Shih MC, Zhu G.
    Stat Med; 2006 Apr 15; 25(7):1149-67. PubMed ID: 16189814
    [Abstract] [Full Text] [Related]

  • 3. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ, Lipsky AM, Berry DA.
    Clin Trials; 2007 Apr 15; 4(1):5-14. PubMed ID: 17327241
    [Abstract] [Full Text] [Related]

  • 4. Group sequential test strategies for superiority and non-inferiority hypotheses in active controlled clinical trials.
    Wang SJ, Hung HM, Tsong Y, Cui L.
    Stat Med; 2001 Jul 15; 20(13):1903-12. PubMed ID: 11427948
    [Abstract] [Full Text] [Related]

  • 5. A framework for two-stage adaptive procedures to simultaneously test non-inferiority and superiority.
    Koyama T, Sampson AR, Gleser LJ.
    Stat Med; 2005 Aug 30; 24(16):2439-56. PubMed ID: 15977285
    [Abstract] [Full Text] [Related]

  • 6. Bayesian predictive power for interim adaptation in seamless phase II/III trials where the endpoint is survival up to some specified timepoint.
    Schmidli H, Bretz F, Racine-Poon A.
    Stat Med; 2007 Nov 30; 26(27):4925-38. PubMed ID: 17590875
    [Abstract] [Full Text] [Related]

  • 7. Choosing the analysis population in non-inferiority studies: per protocol or intent-to-treat.
    Matilde Sanchez M, Chen X.
    Stat Med; 2006 Apr 15; 25(7):1169-81. PubMed ID: 16397861
    [Abstract] [Full Text] [Related]

  • 8. Bayesian design of single-arm phase II clinical trials with continuous monitoring.
    Johnson VE, Cook JD.
    Clin Trials; 2009 Jun 15; 6(3):217-26. PubMed ID: 19528131
    [Abstract] [Full Text] [Related]

  • 9. Optimal choice of the number of treatments to be included in a clinical trial.
    Stallard N, Posch M, Friede T, Koenig F, Brannath W.
    Stat Med; 2009 Apr 30; 28(9):1321-38. PubMed ID: 19243083
    [Abstract] [Full Text] [Related]

  • 10. Bayesian sample size determination in non-sequential clinical trials: Statistical aspects and some regulatory considerations.
    Grouin JM, Coste M, Bunouf P, Lecoutre B.
    Stat Med; 2007 Nov 30; 26(27):4914-24. PubMed ID: 17559054
    [Abstract] [Full Text] [Related]

  • 11. A behavioural Bayes approach to the determination of sample size for clinical trials considering efficacy and safety: imbalanced sample size in treatment groups.
    Kikuchi T, Gittins J.
    Stat Methods Med Res; 2011 Aug 30; 20(4):389-400. PubMed ID: 20223784
    [Abstract] [Full Text] [Related]

  • 12. Bayesian sample size calculations for a non-inferiority test of two proportions in clinical trials.
    Daimon T.
    Contemp Clin Trials; 2008 Jul 30; 29(4):507-16. PubMed ID: 18201944
    [Abstract] [Full Text] [Related]

  • 13. A unifying approach to non-inferiority, equivalence and superiority tests via multiple decision processes.
    Hirotsu C.
    Pharm Stat; 2007 Jul 30; 6(3):193-203. PubMed ID: 17879327
    [Abstract] [Full Text] [Related]

  • 14. Power and sample size computations in simultaneous tests for non-inferiority based on relative margins.
    Dilba G, Bretz F, Hothorn LA, Guiard V.
    Stat Med; 2006 Apr 15; 25(7):1131-47. PubMed ID: 16217842
    [Abstract] [Full Text] [Related]

  • 15. Assessing non-inferiority: a combination approach.
    Gao P, Ware JH.
    Stat Med; 2008 Feb 10; 27(3):392-406. PubMed ID: 17575568
    [Abstract] [Full Text] [Related]

  • 16. Multiple-arm superiority and non-inferiority designs with various endpoints.
    Chang M.
    Pharm Stat; 2007 Feb 10; 6(1):43-52. PubMed ID: 17323311
    [Abstract] [Full Text] [Related]

  • 17. A Bayesian-frequentist two-stage single-arm phase II clinical trial design.
    Dong G, Shih WJ, Moore D, Quan H, Marcella S.
    Stat Med; 2012 Aug 30; 31(19):2055-67. PubMed ID: 22415966
    [Abstract] [Full Text] [Related]

  • 18. Some thoughts on sample size: a Bayesian-frequentist hybrid approach.
    Gordon Lan KK, Wittes JT.
    Clin Trials; 2012 Oct 30; 9(5):561-9. PubMed ID: 22865839
    [Abstract] [Full Text] [Related]

  • 19. A seamless phase II/III design with sample-size re-estimation.
    Bischoff W, Miller F.
    J Biopharm Stat; 2009 Jul 30; 19(4):595-609. PubMed ID: 20183428
    [Abstract] [Full Text] [Related]

  • 20. Flexible design of two-stage adaptive procedures for phase III clinical trials.
    Koyama T.
    Contemp Clin Trials; 2007 Jul 30; 28(4):500-13. PubMed ID: 17307399
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.